National AIDS Trust welcomes Scotland’s decision on long-acting injectable PrEP
Last Updated:Cabotegravir (CAB-LA) will help close the prevention gap for people who face barriers to adhering to oral PrEP.
Cabotegravir (CAB-LA) will help close the prevention gap for people who face barriers to adhering to oral PrEP.
Our calls for the new HIV Action Plan for England
We are deeply disappointed by the decision not to recommend CAB-LA as an HIV prevention option.